Clinical Trial Update: Improving Early Reperfusion With Adjuvant Dornase Alfa in Large Vessel Ischemic Stroke (EXTEND-IA DNase) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial (EXTEND-IA DNase) is evaluating whether adding dornase alfa can improve early reperfusion in large-vessel ischemic stroke; the study is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Dornase alfa (dornase alfa)

Snippet

Sponsor: University of Melbourne | Conditions: Ischemic Stroke | Phase 2 | Status: RECRUITING